West Roxbury, MA, United States of America

Amna Saeed-Kothe

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 8.2

ph-index = 4

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Amna Saeed-Kothe: Innovator in Therapeutic Proteins

Introduction

Amna Saeed-Kothe is a prominent inventor based in West Roxbury, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of innovative proteins for therapeutic applications. With a total of 7 patents, her work focuses on addressing critical health issues related to cholesterol and cardiovascular diseases.

Latest Patents

One of her latest patents involves fibronectin-based scaffold domain proteins that bind PCSK9. This invention relates to the use of these innovative proteins in therapeutic applications aimed at treating atherosclerosis, hypercholesterolemia, and other cholesterol-related diseases. The invention also encompasses cells that comprise such proteins, polynucleotides encoding these proteins or their fragments, and vectors that include the polynucleotides encoding the innovative protein.

Career Highlights

Amna has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of therapeutics.

Collaborations

Throughout her career, Amna has collaborated with esteemed colleagues such as Ray Camphausen and Jonathan Harry Davis. These partnerships have further enhanced her innovative work and expanded the impact of her inventions.

Conclusion

Amna Saeed-Kothe is a trailblazer in the field of biotechnology, with a focus on developing therapeutic proteins that address significant health challenges. Her contributions continue to pave the way for advancements in medical treatments and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…